Steven Zanganeh
Overview
Explore the profile of Steven Zanganeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Martins T, Schmassmann P, Shekarian T, Boulay J, Ritz M, Zanganeh S, et al.
Front Immunol
. 2020 Oct;
11:571951.
PMID: 33117364
Tumor-associated microglia (MG) and macrophages (MΦ) are important components of the glioblastoma (GBM) immune tumor microenvironment (iTME). From the recent advances in understanding how MG and GBM cells evolve and...
12.
Sepand M, Ghavami M, Zanganeh S, Stacks S, Ghasemi F, Montazeri H, et al.
Nanoscale
. 2020 Feb;
12(8):4935-4944.
PMID: 32051994
It is becoming increasingly accepted that various diseases have a capacity to alter the composition of plasma proteins. This alteration in protein composition may consequently change the targeting capacity of...
13.
Hajipour M, Mehrani M, Abbasi S, Amin A, Kassaian S, Garbern J, et al.
Chem Rev
. 2019 Sep;
119(21):11352-11390.
PMID: 31490059
The adult myocardium has a limited regenerative capacity following heart injury, and the lost cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical therapies to resurrect...
14.
Zanganeh S, Georgala P, Corbo C, Arabi L, Ho J, Javdani N, et al.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2019 Aug;
11(6):e1575.
PMID: 31407522
Patients diagnosed with glioblastoma have poor prognosis. Conventional treatment strategies such as surgery, chemotherapy, and radiation therapy demonstrated limited clinical success and have considerable side effects on healthy tissues. A...